Levaquin

Plague, Yersinia pestis, inhaled anthrax caused by Bacillus anthracis + 21 more

Treatment

1 FDA approval

7 Active Studies for Levaquin

What is Levaquin

Levofloxacin

The Generic name of this drug

Treatment Summary

Levofloxacin is an antibiotic that is 8 to 128 times more effective against both gram-positive and gram-negative bacteria than the other isomer of racemic ofloxacin. It is part of the third generation of fluoroquinolones, commonly referred to as the “respiratory quinolones” due to its effectiveness against bacteria associated with respiratory infections. Levofloxacin was first approved by the FDA in 1996, and was quickly approved in many other countries after.

Levaquin

is the brand name

image of different drug pills on a surface

Levaquin Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Levaquin

Levofloxacin

1996

421

Approved as Treatment by the FDA

Levofloxacin, also known as Levaquin, is approved by the FDA for 1 uses like Pseudomonas Infections .

Pseudomonas Infections

Used to treat Nosocomial Pneumonia caused by Pseudomonas Infections in combination with Piperacillin

Effectiveness

How Levaquin Affects Patients

Levofloxacin is an antibiotic that works by stopping bacteria from reproducing. It usually only needs to be taken once or twice per day and can be effective against certain types of bacteria, like Chlamydia and Legionella. However, some bacteria can become resistant to levofloxacin due to changes in their DNA. Cross-resistance between levofloxacin and other antibiotics is unlikely because they work differently. Different areas have different bacteria, so it is important to check local antibiotic resistance patterns before taking levofloxacin.

How Levaquin works in the body

Levofloxacin is an antibiotic that works by blocking two key enzymes in bacteria: DNA gyrase and topoisomerase IV. DNA gyrase helps with DNA replication and topoisomerase IV helps with cell division. Levofloxacin binds to the enzymes and stops them from working, which prevents DNA replication and cell division and ultimately kills the bacteria.

When to interrupt dosage

The advised quantity of Levaquin is contingent upon the diagnosed condition, including Pseudomonas Infections, Abscess and Therapeutic procedure. The dosage also relies on the approach of delivery, as outlined in the table below.

Condition

Dosage

Administration

Yersinia pestis

250.0 mg, 500.0 mg, 750.0 mg, , 5.0 mg/mL, 25.0 mg/mL, 15.0 mg/mL, 7.5 mg/mL, 50.0 mg/mL, 75.0 mg/mL, 240.0 mg, 240.0 mg/mL

, Tablet, film coated, Oral, Tablet, film coated - Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Solution / drops - Ophthalmic, Ophthalmic, Solution / drops, Solution, Solution - Oral, Injection - Intravenous, Injection, Solution - Ophthalmic, Solution - Intravenous, Injection, solution, concentrate - Intravenous, Injection, solution, concentrate, Solution / drops - Topical, Topical, Respiratory (inhalation), Solution - Respiratory (inhalation)

Cystic Fibrosis

250.0 mg, 500.0 mg, 750.0 mg, , 5.0 mg/mL, 25.0 mg/mL, 15.0 mg/mL, 7.5 mg/mL, 50.0 mg/mL, 75.0 mg/mL, 240.0 mg, 240.0 mg/mL

, Tablet, film coated, Oral, Tablet, film coated - Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Solution / drops - Ophthalmic, Ophthalmic, Solution / drops, Solution, Solution - Oral, Injection - Intravenous, Injection, Solution - Ophthalmic, Solution - Intravenous, Injection, solution, concentrate - Intravenous, Injection, solution, concentrate, Solution / drops - Topical, Topical, Respiratory (inhalation), Solution - Respiratory (inhalation)

Pseudomonas Infections

250.0 mg, 500.0 mg, 750.0 mg, , 5.0 mg/mL, 25.0 mg/mL, 15.0 mg/mL, 7.5 mg/mL, 50.0 mg/mL, 75.0 mg/mL, 240.0 mg, 240.0 mg/mL

, Tablet, film coated, Oral, Tablet, film coated - Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Solution / drops - Ophthalmic, Ophthalmic, Solution / drops, Solution, Solution - Oral, Injection - Intravenous, Injection, Solution - Ophthalmic, Solution - Intravenous, Injection, solution, concentrate - Intravenous, Injection, solution, concentrate, Solution / drops - Topical, Topical, Respiratory (inhalation), Solution - Respiratory (inhalation)

Impetigo

250.0 mg, 500.0 mg, 750.0 mg, , 5.0 mg/mL, 25.0 mg/mL, 15.0 mg/mL, 7.5 mg/mL, 50.0 mg/mL, 75.0 mg/mL, 240.0 mg, 240.0 mg/mL

, Tablet, film coated, Oral, Tablet, film coated - Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Solution / drops - Ophthalmic, Ophthalmic, Solution / drops, Solution, Solution - Oral, Injection - Intravenous, Injection, Solution - Ophthalmic, Solution - Intravenous, Injection, solution, concentrate - Intravenous, Injection, solution, concentrate, Solution / drops - Topical, Topical, Respiratory (inhalation), Solution - Respiratory (inhalation)

Wound Infection

250.0 mg, 500.0 mg, 750.0 mg, , 5.0 mg/mL, 25.0 mg/mL, 15.0 mg/mL, 7.5 mg/mL, 50.0 mg/mL, 75.0 mg/mL, 240.0 mg, 240.0 mg/mL

, Tablet, film coated, Oral, Tablet, film coated - Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Solution / drops - Ophthalmic, Ophthalmic, Solution / drops, Solution, Solution - Oral, Injection - Intravenous, Injection, Solution - Ophthalmic, Solution - Intravenous, Injection, solution, concentrate - Intravenous, Injection, solution, concentrate, Solution / drops - Topical, Topical, Respiratory (inhalation), Solution - Respiratory (inhalation)

Community Acquired Pneumonia (CAP) caused by susceptible bacteria

250.0 mg, 500.0 mg, 750.0 mg, , 5.0 mg/mL, 25.0 mg/mL, 15.0 mg/mL, 7.5 mg/mL, 50.0 mg/mL, 75.0 mg/mL, 240.0 mg, 240.0 mg/mL

, Tablet, film coated, Oral, Tablet, film coated - Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Solution / drops - Ophthalmic, Ophthalmic, Solution / drops, Solution, Solution - Oral, Injection - Intravenous, Injection, Solution - Ophthalmic, Solution - Intravenous, Injection, solution, concentrate - Intravenous, Injection, solution, concentrate, Solution / drops - Topical, Topical, Respiratory (inhalation), Solution - Respiratory (inhalation)

furuncle

250.0 mg, 500.0 mg, 750.0 mg, , 5.0 mg/mL, 25.0 mg/mL, 15.0 mg/mL, 7.5 mg/mL, 50.0 mg/mL, 75.0 mg/mL, 240.0 mg, 240.0 mg/mL

, Tablet, film coated, Oral, Tablet, film coated - Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Solution / drops - Ophthalmic, Ophthalmic, Solution / drops, Solution, Solution - Oral, Injection - Intravenous, Injection, Solution - Ophthalmic, Solution - Intravenous, Injection, solution, concentrate - Intravenous, Injection, solution, concentrate, Solution / drops - Topical, Topical, Respiratory (inhalation), Solution - Respiratory (inhalation)

Pyoderma

250.0 mg, 500.0 mg, 750.0 mg, , 5.0 mg/mL, 25.0 mg/mL, 15.0 mg/mL, 7.5 mg/mL, 50.0 mg/mL, 75.0 mg/mL, 240.0 mg, 240.0 mg/mL

, Tablet, film coated, Oral, Tablet, film coated - Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Solution / drops - Ophthalmic, Ophthalmic, Solution / drops, Solution, Solution - Oral, Injection - Intravenous, Injection, Solution - Ophthalmic, Solution - Intravenous, Injection, solution, concentrate - Intravenous, Injection, solution, concentrate, Solution / drops - Topical, Topical, Respiratory (inhalation), Solution - Respiratory (inhalation)

Hospital acquired pneumonia

250.0 mg, 500.0 mg, 750.0 mg, , 5.0 mg/mL, 25.0 mg/mL, 15.0 mg/mL, 7.5 mg/mL, 50.0 mg/mL, 75.0 mg/mL, 240.0 mg, 240.0 mg/mL

, Tablet, film coated, Oral, Tablet, film coated - Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Solution / drops - Ophthalmic, Ophthalmic, Solution / drops, Solution, Solution - Oral, Injection - Intravenous, Injection, Solution - Ophthalmic, Solution - Intravenous, Injection, solution, concentrate - Intravenous, Injection, solution, concentrate, Solution / drops - Topical, Topical, Respiratory (inhalation), Solution - Respiratory (inhalation)

Communicable Diseases

250.0 mg, 500.0 mg, 750.0 mg, , 5.0 mg/mL, 25.0 mg/mL, 15.0 mg/mL, 7.5 mg/mL, 50.0 mg/mL, 75.0 mg/mL, 240.0 mg, 240.0 mg/mL

, Tablet, film coated, Oral, Tablet, film coated - Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Solution / drops - Ophthalmic, Ophthalmic, Solution / drops, Solution, Solution - Oral, Injection - Intravenous, Injection, Solution - Ophthalmic, Solution - Intravenous, Injection, solution, concentrate - Intravenous, Injection, solution, concentrate, Solution / drops - Topical, Topical, Respiratory (inhalation), Solution - Respiratory (inhalation)

Cellulitis

250.0 mg, 500.0 mg, 750.0 mg, , 5.0 mg/mL, 25.0 mg/mL, 15.0 mg/mL, 7.5 mg/mL, 50.0 mg/mL, 75.0 mg/mL, 240.0 mg, 240.0 mg/mL

, Tablet, film coated, Oral, Tablet, film coated - Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Solution / drops - Ophthalmic, Ophthalmic, Solution / drops, Solution, Solution - Oral, Injection - Intravenous, Injection, Solution - Ophthalmic, Solution - Intravenous, Injection, solution, concentrate - Intravenous, Injection, solution, concentrate, Solution / drops - Topical, Topical, Respiratory (inhalation), Solution - Respiratory (inhalation)

Abscess

250.0 mg, 500.0 mg, 750.0 mg, , 5.0 mg/mL, 25.0 mg/mL, 15.0 mg/mL, 7.5 mg/mL, 50.0 mg/mL, 75.0 mg/mL, 240.0 mg, 240.0 mg/mL

, Tablet, film coated, Oral, Tablet, film coated - Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Solution / drops - Ophthalmic, Ophthalmic, Solution / drops, Solution, Solution - Oral, Injection - Intravenous, Injection, Solution - Ophthalmic, Solution - Intravenous, Injection, solution, concentrate - Intravenous, Injection, solution, concentrate, Solution / drops - Topical, Topical, Respiratory (inhalation), Solution - Respiratory (inhalation)

Prostatitis

250.0 mg, 500.0 mg, 750.0 mg, , 5.0 mg/mL, 25.0 mg/mL, 15.0 mg/mL, 7.5 mg/mL, 50.0 mg/mL, 75.0 mg/mL, 240.0 mg, 240.0 mg/mL

, Tablet, film coated, Oral, Tablet, film coated - Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Solution / drops - Ophthalmic, Ophthalmic, Solution / drops, Solution, Solution - Oral, Injection - Intravenous, Injection, Solution - Ophthalmic, Solution - Intravenous, Injection, solution, concentrate - Intravenous, Injection, solution, concentrate, Solution / drops - Topical, Topical, Respiratory (inhalation), Solution - Respiratory (inhalation)

Pseudomonas Infections

250.0 mg, 500.0 mg, 750.0 mg, , 5.0 mg/mL, 25.0 mg/mL, 15.0 mg/mL, 7.5 mg/mL, 50.0 mg/mL, 75.0 mg/mL, 240.0 mg, 240.0 mg/mL

, Tablet, film coated, Oral, Tablet, film coated - Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Solution / drops - Ophthalmic, Ophthalmic, Solution / drops, Solution, Solution - Oral, Injection - Intravenous, Injection, Solution - Ophthalmic, Solution - Intravenous, Injection, solution, concentrate - Intravenous, Injection, solution, concentrate, Solution / drops - Topical, Topical, Respiratory (inhalation), Solution - Respiratory (inhalation)

Communicable Diseases

250.0 mg, 500.0 mg, 750.0 mg, , 5.0 mg/mL, 25.0 mg/mL, 15.0 mg/mL, 7.5 mg/mL, 50.0 mg/mL, 75.0 mg/mL, 240.0 mg, 240.0 mg/mL

, Tablet, film coated, Oral, Tablet, film coated - Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Solution / drops - Ophthalmic, Ophthalmic, Solution / drops, Solution, Solution - Oral, Injection - Intravenous, Injection, Solution - Ophthalmic, Solution - Intravenous, Injection, solution, concentrate - Intravenous, Injection, solution, concentrate, Solution / drops - Topical, Topical, Respiratory (inhalation), Solution - Respiratory (inhalation)

Sinusitis

250.0 mg, 500.0 mg, 750.0 mg, , 5.0 mg/mL, 25.0 mg/mL, 15.0 mg/mL, 7.5 mg/mL, 50.0 mg/mL, 75.0 mg/mL, 240.0 mg, 240.0 mg/mL

, Tablet, film coated, Oral, Tablet, film coated - Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Solution / drops - Ophthalmic, Ophthalmic, Solution / drops, Solution, Solution - Oral, Injection - Intravenous, Injection, Solution - Ophthalmic, Solution - Intravenous, Injection, solution, concentrate - Intravenous, Injection, solution, concentrate, Solution / drops - Topical, Topical, Respiratory (inhalation), Solution - Respiratory (inhalation)

Urinary tract infection

250.0 mg, 500.0 mg, 750.0 mg, , 5.0 mg/mL, 25.0 mg/mL, 15.0 mg/mL, 7.5 mg/mL, 50.0 mg/mL, 75.0 mg/mL, 240.0 mg, 240.0 mg/mL

, Tablet, film coated, Oral, Tablet, film coated - Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Solution / drops - Ophthalmic, Ophthalmic, Solution / drops, Solution, Solution - Oral, Injection - Intravenous, Injection, Solution - Ophthalmic, Solution - Intravenous, Injection, solution, concentrate - Intravenous, Injection, solution, concentrate, Solution / drops - Topical, Topical, Respiratory (inhalation), Solution - Respiratory (inhalation)

Bacterial conjunctivitis

250.0 mg, 500.0 mg, 750.0 mg, , 5.0 mg/mL, 25.0 mg/mL, 15.0 mg/mL, 7.5 mg/mL, 50.0 mg/mL, 75.0 mg/mL, 240.0 mg, 240.0 mg/mL

, Tablet, film coated, Oral, Tablet, film coated - Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Solution / drops - Ophthalmic, Ophthalmic, Solution / drops, Solution, Solution - Oral, Injection - Intravenous, Injection, Solution - Ophthalmic, Solution - Intravenous, Injection, solution, concentrate - Intravenous, Injection, solution, concentrate, Solution / drops - Topical, Topical, Respiratory (inhalation), Solution - Respiratory (inhalation)

Therapeutic procedure

250.0 mg, 500.0 mg, 750.0 mg, , 5.0 mg/mL, 25.0 mg/mL, 15.0 mg/mL, 7.5 mg/mL, 50.0 mg/mL, 75.0 mg/mL, 240.0 mg, 240.0 mg/mL

, Tablet, film coated, Oral, Tablet, film coated - Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Solution / drops - Ophthalmic, Ophthalmic, Solution / drops, Solution, Solution - Oral, Injection - Intravenous, Injection, Solution - Ophthalmic, Solution - Intravenous, Injection, solution, concentrate - Intravenous, Injection, solution, concentrate, Solution / drops - Topical, Topical, Respiratory (inhalation), Solution - Respiratory (inhalation)

Plague

250.0 mg, 500.0 mg, 750.0 mg, , 5.0 mg/mL, 25.0 mg/mL, 15.0 mg/mL, 7.5 mg/mL, 50.0 mg/mL, 75.0 mg/mL, 240.0 mg, 240.0 mg/mL

, Tablet, film coated, Oral, Tablet, film coated - Oral, Tablet, Tablet - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Solution / drops - Ophthalmic, Ophthalmic, Solution / drops, Solution, Solution - Oral, Injection - Intravenous, Injection, Solution - Ophthalmic, Solution - Intravenous, Injection, solution, concentrate - Intravenous, Injection, solution, concentrate, Solution / drops - Topical, Topical, Respiratory (inhalation), Solution - Respiratory (inhalation)

Warnings

Levaquin Contraindications

Condition

Risk Level

Notes

Severe Hypersensitivity Reactions

Do Not Combine

Levofloxacin may interact with Pulse Frequency

There are 20 known major drug interactions with Levaquin.

Common Levaquin Drug Interactions

Drug Name

Risk Level

Description

Abemaciclib

Major

The excretion of Abemaciclib can be decreased when combined with Levofloxacin.

Amiodarone

Major

The risk or severity of QTc prolongation can be increased when Levofloxacin is combined with Amiodarone.

Amitriptyline

Major

Levofloxacin may increase the QTc-prolonging activities of Amitriptyline.

Anagrelide

Major

The risk or severity of QTc prolongation can be increased when Levofloxacin is combined with Anagrelide.

Arsenic trioxide

Major

The risk or severity of QTc prolongation can be increased when Levofloxacin is combined with Arsenic trioxide.

Levaquin Toxicity & Overdose Risk

Levofloxacin has a low risk of acute toxicity. In tests, high doses of levofloxacin caused symptoms such as unsteadiness, drooping eyelids, reduced movement, difficulty breathing, shaking, and seizures. If someone overdoses on levofloxacin, they should have their stomach emptied and receive general supportive care. It is also recommended to monitor the patient's heart rhythm to make sure it is within a normal range. Dialysis is not very effective in removing levofloxacin from the body in cases of overdose.

image of a doctor in a lab doing drug, clinical research

Levaquin Novel Uses: Which Conditions Have a Clinical Trial Featuring Levaquin?

An active clinical trial is currently investigating the potential of Levaquin in the treatment of Urinary tract infection, Pyoderma and Yersinia pestis.

Condition

Clinical Trials

Trial Phases

Bronchitis

6 Actively Recruiting

Not Applicable, Phase 4, Phase 2

Wound Infection

0 Actively Recruiting

inhaled anthrax caused by Bacillus anthracis

0 Actively Recruiting

Prostatitis

0 Actively Recruiting

Cellulitis

0 Actively Recruiting

Pseudomonas Infections

0 Actively Recruiting

Pseudomonas Infections

0 Actively Recruiting

Communicable Diseases

0 Actively Recruiting

Urinary tract infection

0 Actively Recruiting

Hospital acquired pneumonia

0 Actively Recruiting

Sinusitis

0 Actively Recruiting

Yersinia pestis

0 Actively Recruiting

Plague

0 Actively Recruiting

Communicable Diseases

0 Actively Recruiting

Pyoderma

1 Actively Recruiting

Phase 2

Impetigo

0 Actively Recruiting

furuncle

0 Actively Recruiting

Community Acquired Pneumonia (CAP) caused by susceptible bacteria

0 Actively Recruiting

Urinary tract infection

0 Actively Recruiting

Communicable Diseases

0 Actively Recruiting

Levaquin Reviews: What are patients saying about Levaquin?

3.3

Patient Review

8/31/2018

Levaquin for Pneumonia caused by Bacteria

I was given this medication for pleurisy and it took care of the infection. However, I was left with incredibly painful joints- to the point where I could barely walk or take stairs. I've been tested for arthritis and other conditions, but none have come back positive. It's clear to me that this drug has done serious damage, and though I'm getting better, it's a long road ahead. Thank goodness my husband is able to help care for me- otherwise I would be in a nursing home at this point.

2.3

Patient Review

3/25/2018

Levaquin for Pneumonia caused by Bacteria

I was prescribed Levofloxacin 750 mg tablets for 7 days for bacterial pneumonia. I started taking the drug on a Friday and it is now Sunday. I haven't slept since I started taking this drug. After reading the reviews on here, Azithromycin seems to be much more tolerated without all the side effects.

2

Patient Review

1/9/2022

Levaquin for Bacterial Urinary Tract Infection

I took Levofloxacin for 10 days and developed severe tendonitis a few days in. This eventually went away, but I also started having digestive issues around the same time. This led to Gastroparesis, which is a condition where your stomach can't empty properly. I don't recommend this drug at all and think it should be banned in the United States. If your doctor prescribes it, get a different antibiotic!

1

Patient Review

1/18/2019

Levaquin for Bacterial Infection with Bronchitis

I took one dose of this drug and was awake for 72 hours. Itchy, tingly skin, constipated, and knee pain. I hope my message is heard clearly: do not prescribe this medication.

1

Patient Review

5/11/2020

Levaquin for Bacterial Infection of Kidney due to E. Coli Organism

I was prescribed 5 doses of 250 mg. Only took 2 doses and i have had massive headaches all over my head, unbearable sinus pressure and tendon pain. I havent taken in 5 days and headaches are not going away.

1

Patient Review

5/8/2020

Levaquin for Bacterial Urinary Tract Infection

This drug only worked for five days, and I still feel the effects even though it's been three weeks since I stopped taking it. Definitely do not recommend.

1

Patient Review

11/18/2020

Levaquin for Bacterial Urinary Tract Infection

I went to the doctor with a low fever and was diagnosed with possibly having urinary tract or bronchitis. I took one pill as directed, but then had diarrhea nonstop for over a week. Now I'm just waiting for the results of a stool sample. In my opinion, this pill is too strong and has way too many side effects.

1

Patient Review

7/27/2022

Levaquin for infection caused by bacteria

I had an incredibly severe reaction to this treatment, with swelling and rashes all over my body. I was given medication to try and counteract the effects, but it still lingered for weeks afterwards. Do not recommend.

1

Patient Review

7/22/2022

Levaquin for Bacterial Urinary Tract Infection

I was prescribed 5 pills of levofloxacin of 650 mgs each, one per day. After the third dose I developed Insomnia, hand tremors and Tendinitis. Side effects evolved and in two weeks I was no longer able to walk. I spent months on a wheelchair with an acute case of fluoroquinolone toxicity. This drug almost killed me. My life and health had completely deteriorated by this dangerous antibiotic that doctors prescribe indiscriminately.

1

Patient Review

3/19/2021

Levaquin for Acute Bacterial Infection of the Sinuses

My sinus infection only got worse after taking this medication. I lost all hearing in my left ear and it's been three years with no improvement.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about levaquin

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Why was Levaquin taken off the market?

"Kelsey Buckholtz, a spokeswoman for Janssen, said that they decided to discontinue Levaquin because there are a lot of other treatment options available and they want to focus on developing new medicines."

Answered by AI

What are side effects of Levaquin?

"You may experience some or all of the following side effects: nausea, vomiting, diarrhea, headache, constipation, difficulty sleeping (insomnia), dizziness, abdominal pain."

Answered by AI

What is Levaquin used to treat?

"It will not work for viral infections (such as common cold, flu).

Levofloxacin is used to treat a variety of bacterial infections. This medication belongs to a class of drugs known as quinolone antibiotics. These drugs work by interfering with the production of essential proteins needed by bacteria to survive. This particular antibiotic is effective against a wide variety of bacteria. However, it is important to remember that this drug will not work against viral infections."

Answered by AI

Is Levaquin and amoxicillin the same?

"Both Levaquin and amoxicillin are antibiotics used to treat infections. Levaquin is a fluoroquinolone and amoxicillin is a penicillin. They are both used to treat infections of the lungs, airways, skin, urinary tract, and ears. The main difference between the two drugs is the conditions they are used to treat."

Answered by AI

Clinical Trials for Levaquin

Image of McGill University Health Centre in Montreal, Canada.

Oscillatory Positive Expiratory Pressure Therapy for COPD

18+
All Sexes
Montreal, Canada

The goal of this non-pharmacologic interventional study is to learn if Oscillatory Positive Expiratory Pressure (OPEP) therapy can improve disease impact and respiratory system dynamics in patients with COPD. The main questions it aims to answer are: Is OPEP therapy able to improve the impact of cough symptoms as measured on a validated symptom score? Is OPEP therapy able to improve the properties of the lung (called reactance) as measured by oscillometry? Researchers will compare the results of the same tests performed before and after 4 weeks of OPEP treatment to see if OPEP treatment improves cough symptoms and lung mechanics. * Participants with COPD will complete in-person baseline tests and will then receive the smart OPEP device. * These participants will then use the smart OPEP device at home, at least twice a day, for 4 consecutive weeks. * Finally, these participants will return to complete in-person end-of-study tests.

Recruiting
Has No Placebo

McGill University Health Centre

Bryan A. Ross, MD, MSc (Physiol), MSc (Epi)

Trudell Medical International

Have you considered Levaquin clinical trials?

We made a collection of clinical trials featuring Levaquin, we think they might fit your search criteria.
Go to Trials
Image of El Camino Hospital in Mountain View, United States.

RejuvenAir System for Chronic Bronchitis

40 - 80
All Sexes
Mountain View, CA

Chronic Obstructive Pulmonary Disease (COPD) is defined as an impaired ability to move air within the lungs and is a major public health problem that is projected to rank fifth worldwide in terms of disease burden and third in terms of mortality. Chronic bronchitis (CB) is a common clinical phenotype within the umbrella of a COPD diagnosis and is classically defined as chronic cough and sputum production for 3 months a year for 2 consecutive years2, but many studies have used different definitions to define it- chronic cough and sputum production for one year or cough and sputum production on most days of the week. CB is associated with multiple clinical consequences, including; the worsening of lung function decline, increasing risk of acute exacerbations of COPD, increased risk of developing pneumonia, reduced health related quality of life, and an increase in all-cause mortality.

Waitlist Available
Quick Reply
Device

El Camino Hospital (+26 Sites)

Gerard Criner, MD

CSA Medical, Inc.